期刊文献+

大豆苷元抑制人成骨样MG-63细胞分泌IL-6的分子机制研究 被引量:5

Molecular mechanism of daidzein on inhibiting IL-6 secretion in human osteoblast-like MG-63 cells
原文传递
导出
摘要 【目的】研究大豆苷元抑制人成骨样MG-63细胞分泌IL-6的分子机制。【方法】选用兼有两种雌激素受体(estrogen receptor,ER)亚型表达的人成骨样MG-63细胞作为细胞模型,应用RT-PCR、ELISA、荧光素酶报告基因检测及小RNA干扰技术,研究大豆苷元对人成骨样MG-63细胞分泌骨吸收调节因子IL-6的作用及其分子机制。【结果】大豆苷元可降低MG-63细胞IL-6的分泌,抑制mRNA表达和基因启动子的转录活性,上述作用能够被ER阻断剂ICI 182,780所阻断。小RNA干扰技术进一步证实大豆苷元对MG-63细胞IL-6表达的抑制作用主要由ERα介导。【结论】大豆苷元可以抑制人成骨样MG-63细胞分泌IL-6,其调节作用与ER通路有关,主要由ERα介导。 【Objective】To study the molecular mechanism of daidzein on inhibiting IL-6 secretion in human osteoblast-like MG-63 cells.【Methods】Human osteoblast-like MG-63 cells containing two estrogen-receptor(ER)isoforms were chosen as a suitable cell model for this study.RT-PCR,enzyme-linked immunosorbent assay(ELISA),luciferase reporter assay and small interfering RNA technology were performed to study the effect of daidzein on IL-6 secretion in osteoblast-like MG-63 cells and underlie its molecular mechanism.【Results】Daidzein obviously inhibited the IL-6 secretion,mRNA expression and IL-6 promoter activity in human osteoblastic MG-63 cells,which could be abrogated by ER antagonist ICI 182,780.By siRNA technology,it was further demonstrated that the inhibition of daidzein on IL-6 expression was mediated by ERα.【Conclusion】The effect of daidzein on IL-6 secretion in human osteoblast-like MG-63 cells is associated with ER pathway and mainly mediated by ERα.
作者 李乐飞 金鑫 李程育 高丹丹 温晓昶 王越 LI Le-fei;JIN Xin;LI Cheng-yu;GAO Dan-dan;WEN Xiao-chang;WANG Yue(Department of Stomatology,Medical College of Beihua University,Jilin 132013,China)
出处 《武警后勤学院学报(医学版)》 CAS 2018年第6期467-471,共5页 Journal of Logistics University of PAP(Medical Sciences)
基金 国家自然科学基金项目(81572852) 天津市自然科学基金项目(18JCZDJC33200) 武警后勤学院科学技术研究项目(WHJ201712 WHJ201713)
关键词 大豆苷元 成骨细胞 白细胞介素-6 雌激素受体 Daidzein Osteoblast interleukin 6 Estrogen receptor
  • 相关文献

参考文献2

二级参考文献16

  • 1刘宏伟,杨式之,徐克慧,李洪洋,谭建三.尼尔雌醇预防大鼠卵巢切除后骨质疏松[J].华西医科大学学报,1993,24(1):40-44. 被引量:15
  • 2Lanyon L,Armstrong V,Ong D,et al.Is estrogen receptor alpha key to controlling bones' resistance to fracture? J Endocrinol,2004,182(2):183-191.
  • 3Hofbauer LC,Kihne CA,Viereck V.The OPG/RANKL/RANK system in metabolic bone diseases.J Musculoskel Neuron Interact,2004,4(3):268-275.
  • 4Scheidt-Nave C,Bismar H,Leidig-Bruckner G,et al.Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.J Clin Endocrinol Metab,2001,86(5):2032-2042.
  • 5De Benedetti F,Pignatti P,Vivarelli M.et al.In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist.J Immunol,2001,166(7):4334-4340.
  • 6Blanchard F,Duplomb L,Baud'huin M,et al.The dual role of IL-6-type cytokines on bone remodeling and bone tumors.Cytokine Growth Factor Rev,2009,20(1):19-28.
  • 7Wiren KM,Chapman Evans A,Zhang XW.Osteoblast differentiation influences androgen and estrogen receptor-alpha and-beta expression.J Endocrinol,2002,175(3):683-694.
  • 8Braidman IP,Hainey L,Batra G,et al.Localization of estrogen receptor beta protein expression in adult human bone.J Bone Miner Res,2001,16(2):214-220.
  • 9Sorensen MG.Henriksen K,Dziegiel MH,et al.Estrogen directly attenuates human osteocIastogenesis,but has no effect on resorption by mature osteoclasts.DNA Cell Biol,2006,25(8):475-483.
  • 10Kallio A,Guo T,Lamminen E,et al.Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.Mol Cell Endocrinol,2008,289(1-2):38-48.

共引文献32

同被引文献112

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部